Upgrade to SI Premium - Free Trial

Form SCHEDULE 13G/A C4 Therapeutics, Inc. Filed by: WASATCH ADVISORS LP

April 22, 2026 5:28 PM





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G



Wasatch Advisors LP
Signature:Mike Yeates
Name/Title:CEO
Date:04/22/2026

Categories

SEC Filings